Lynx and Clalit will work together to facilitate medical research, development and new innovation opportunities in healthcare data
PALO ALTO, Calif., June 16, 2022 /PRNewswire/ — Lynx® and Clalit Health Serviceslargest provider of public and semi-private healthcare services in Israel, today announced a partnership to provide access to Clalit’s extensive medical database via the Lynx platform. Clalit will use Lynx’s platform to enable research and development by securely sharing anonymized medical data with startups, industry partners and academic researchers.
In 2021, more than $1 billion has been invested in healthcare startups in Israel, empowering hundreds of entrepreneurs to develop life-changing products and services to improve healthcare around the world. Companies have collected a wide variety of medical data that could be used to further improve medical devices, create new AI models for research, and develop new treatments, drugs, and diagnostic tools. Until now, it has been difficult to provide access to this depth and breadth of data in a secure and privacy-compliant way.
“Israel’s health system data repositories are an invaluable resource for developing innovative solutions that lead to meaningful improvements in the health services we provide,” says Professor Ran Balicer, Chief Innovation Officer at Clalit Health Services and founding director of Clalit Research. Institute. “The partnership between Clalit and Lynx MD is a big step forward in our ability to scale healthcare innovation through safe and efficient access to anonymized real-world patient data.
“Clalit is the largest and most important HMO in Israel and is committed to researching and developing ideas that can contribute to the improvement and advancement of Israel’s health care system. The partnership between Clalit and Lynx MD provides the foundation to conduct groundbreaking research in a streamlined and efficient manner, in a way that protects patient information,” adds Liora SchechterDirector of Information Systems and Digital at Clalit.
Lynx MD, which announced a $12 million investment in 2021, is a digital health startup founded by Omer Dror, Ofir Farchyand dr. Robert Eisdorfer in 2019. The Lynx MD cloud platform enables healthcare organizations to provide access to medical data, including unstructured data such as medical records, imaging, genomics and others, in a secure and confidentiality compliant. Through the platform, healthcare organizations can access clinical data using the management and monitoring tools provided by the platform, and healthcare researchers and developers have easy access. to real, high-quality medical data.
According Omer DrorCEO and Co-Founder of Lynx MD, “This partnership is a giant leap in lowering the barriers to bringing data, clinicians and developers together to tackle the toughest health issues. As a result, we have l ‘opportunity to develop the infrastructure that enables medical innovation on a scale never seen before.’
Lynx is the leading cloud-based platform that unlocks real health data at scale. The platform enables the sharing and analysis of rich, unstructured data, securely connecting healthcare organizations with the life sciences and medical technology community. Lynx provides an environment for deep learning studies, allowing researchers to study data from multiple sources. For more information, visit Lynx®.
This version was released via WebWire®. For more information, visit http://www.webwire.com.